Our results provide insight into the possible early brain molecular effects of an EOfAD mutation in human SORL1. Differential effects of heterozygosity and complete loss of normal SORL1 expression are revealed. This evidence concerns the gene SORL1 and early-onset autosomal dominant Alzheimer disease.